Literature DB >> 12474215

Development, validation and analytical error function of two chromatographic methods with fluorimetric detection for the determination of bisoprolol and metoprolol in human plasma.

Antonio J Braza1, Pilar Modamio, Cecilia F Lastra, Eduardo L Mariño.   

Abstract

This work describes two high-performance liquid chromatographic methods for the individual determination of bisoprolol and metoprolol in human plasma. Analytical methods involve two different liquid-liquid extractions of human plasma, with diethyl ether for bisoprolol and with dichloromethane for metoprolol, coupled with a similar Nucleosil C(18) reversed-phase HPLC column. Fluorimetric detection was used to identify both beta-blockers. Retention times for bisoprolol and metoprolol were 8.7 and 3.2 min, respectively. Linear regressions for the calibration curves were linear at a concentration range of 6.25-200 ng/mL. Intra- and inter-day precision coefficients of variations and accuracy bias were acceptable (within 15%) over the entire range for both drugs. Average recovery was 89% for metoprolol and 98% for bisoprolol. Once the methods had been validated, analytical error functions were established as standard deviation (SD; ng/mL) = 2.216 + 3.608 x 10(-4)C(2) (C = theoretical concentration value) and SD-(ng/mL) = 0.408 + 0.378 x 10(-1)C for bisoprolol and metoprolol, respectively. The methods developed and their associated analytical error functions will be suitable for pharmacokinetic studies and for determination of plasma concentration if posology individualization of these drugs is needed. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12474215     DOI: 10.1002/bmc.195

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  2 in total

1.  Development and validation of a simultaneous HPLC method for estimation of bisoprolol fumarate and amlodipine besylate from tablets.

Authors:  D N Vora; A A Kadav
Journal:  Indian J Pharm Sci       Date:  2008 Jul-Aug       Impact factor: 0.975

2.  Development and evaluation of fixed dose bi therapy sublingual tablets for treatment stress hypertension and anxiety.

Authors:  Mohamed A El-Nabarawi; Saadia A Tayel; Nadia A Soliman; Hadel A Abo Enin
Journal:  J Pharm Bioallied Sci       Date:  2013-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.